Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine
Clinical trial NCT01980836 · UNKNOWN
Trial details
- NCT number
- NCT01980836
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.